←
Beat Childhood Cancer2,611 posts
Beat Childhood Cancer avatar

Beat Childhood Cancer

@beatccorg

Bringing hope to kids battling childhood cancers, through innovative clinical trials & research for #EveryChildEveryWhere

◷ Joined May 2009▧ 311 Photos and videos
Beat Childhood Cancer avatar
Beat Childhood Cancer@beatccorg·31 Dec 2025

2025 was a year of progress, purpose, and heart. 💛 In 2025, our community turned hope into action. Thank you for being the heartbeat of this movement. Together, we’re not just beating childhood cancer, we are rewriting what IS possible. #BeatChildhoodCancer

0:17
Beat Childhood Cancer avatar
Beat Childhood Cancer@beatccorg·28 Dec 2025

Dr. Francis Eshun and the team at Site 17- Phoenix Children's, Phoenix, AZ are officially approved to enroll on BCC021– Phase I/II study of Silmitasertib (CX-4945) in combination with chemotherapy in children and young adults with relapsed refractory solid tumors.

Post attachment
Beat Childhood Cancer avatar
Beat Childhood Cancer@beatccorg·24 Dec 2025

From our Beat Childhood Cancer family to yours, we’re wishing you a season filled with warmth, hope, and health. Thank you for helping us bring light to families facing the unimaginable. Merry Christmas and Happy Holidays! May all your days be merry and bright.

Post attachment
Beat Childhood Cancer avatar
Beat Childhood Cancer@beatccorg·23 Dec 2025

Dr. Michael Isakoff and the team at Site 09 – Connecticut Children's Medical Center, Hartford, CT are officially approved to enroll on BCC020– A Dose Escalation Study Using Eflornithine (DFMO) and AMXT 1501.

Post attachment
Beat Childhood Cancer avatar
Beat Childhood Cancer@beatccorg·23 Dec 2025

Today marks 51/52 of Take Action Tuesday, and this second-to-last Take Action Tuesday of the year is all about getting active. Introducing Run 26 in ’26! We’re looking for 26 people to commit to 26.2 miles in 2026 in support of Beat Childhood Cancer: beatcc.org/eventinterest/

Post attachment
Beat Childhood Cancer avatar
Beat Childhood Cancer@beatccorg·22 Dec 2025

Dr. Monia Marzouki and the team at Site 84- CHU Sainte Justine, Montreal, QC, Canada are officially approved to enroll on BCC021– Phase I/II study of Silmitasertib (CX-4945) in combination with chemotherapy in children and young adults with relapsed refractory solid tumors.

Post attachment
Beat Childhood Cancer avatar
Beat Childhood Cancer@beatccorg·19 Dec 2025

Dr. Daniel Benedetti and the team at Vanderbilt-Ingram Cancer Center in Nashville, TN are officially approved to enroll on BCC021– Phase I/II study of Silmitasertib (CX-4945) in combination with chemotherapy in children and young adults with relapsed refractory solid tumors.

Post attachment
Beat Childhood Cancer avatar
Beat Childhood Cancer@beatccorg·13 Dec 2025

Dr. Jennifer Dean and her team at Site 24 - All Children's in St Petersburg, FL are now officially approved to enroll on BCC016– Phase II Trial of Eflornithine/DFMO as Maintenance Therapy for Molecular High Risk/Very High Risk and Relapsed/Refractory Medulloblastoma.

Post attachment
Beat Childhood Cancer avatar
Beat Childhood Cancer@beatccorg·12 Dec 2025

Dr. William Roberts and his team at Site 03 - Rady Children’s in San Diego, CA are officially approved to enroll on BCC021– Phase I/II study of Silmitasertib (CX-4945) in combination with chemotherapy in children and young adults with relapsed refractory solid tumors.

Post attachment
Beat Childhood Cancer avatar
Beat Childhood Cancer@beatccorg·9 Dec 2025

Today is Week 49/52 of Take Action Tuesday which means there are just 4 Tuesdays left in 2025 to make your impact! Our BeatCC merch shop is stocked with new holiday items. Shop with purpose today: beatcc.org/shop Because taking action can be as simple as what you wear.

Post attachment